Acta Med. 2019, 62: 137-146

https://doi.org/10.14712/18059694.2020.2

Association of IL-6 −174 G>C Polymorphism with Susceptibility to Colorectal Cancer and Gastric Cancer: a Systematic Review and Meta-Analysis

Jamal Jafari-Nedooshana, Seyed Alireza Dastgheibb, Saeed Kargara, Mohammad Zarea, Ali Raee-Ezzabadic, Naeimeh Heiranizadeha, Jalal Sadeghizadeh-Yazdid, Hossein Neamatzadehe,f

aDepartment of General Surgery, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
bDepartment of Medical Genetics, School of Medicine, Shiraz Sadoughi University of Medical Sciences, Shiraz, Iran
cDepartment of Emergency Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
dDepartment of Food Science and Technology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
eDepartment of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
fMother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Received July 2, 2019
Accepted September 4, 2019

References

1. Namazi A, Abedinzadeh M, Nourbaksh P, Neamatzadeh H. Association between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: a meta analysis of 5,193 cases and 6,645 controls. Asian Pac J Cancer Prev 2015; 16(6): 2263–8. <https://doi.org/10.7314/APJCP.2015.16.6.2263>
2. Khoram-Abadi KM, Forat-Yazdi M, Kheirandish S, et al. DNMT3B −149 C&gt;T and −579 G&gt;T polymorphisms and risk of gastric and colorectal cancer: A meta-analysis. Asian Pacific J Cancer Prev 2016; 17(6): 3015–20.
3. Namazi A, Forat-Yazdi M, Jafari MA, et al. Association between polymorphisms of ERCC5 gene and susceptibility to gastric cancer: A systematic review and meta-analysis. Asian Pacific J Cancer Prev 2017; 18(10): 2611–7.
4. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017; 66(4): 683–91. <https://doi.org/10.1136/gutjnl-2015-310912>
5. Khazaei S, Rezaeian S, Soheylizad M, Khazaei S, Biderafsh A. Global Incidence and Mortality Rates of Stomach Cancer and the Human Development Index: an Ecological Study. Asian Pac J Cancer Prev 2016; 17(4): 1701–4. <https://doi.org/10.7314/APJCP.2016.17.4.1701>
6. Forat-Yazdi M, Gholi-Nataj M, Neamatzadeh H, Nourbakhsh P, Shaker- Ardakani H. Association of XRCC1 Arg399Gln polymorphism with colorectal cancer risk: A huge meta analysis of 35 studies. Asian Pacific J Cancer Prev 2015; 16(8): 3285–91. <https://doi.org/10.7314/APJCP.2015.16.8.3285>
7. Namazi A, Forat-Yazdi M, Jafari M, et al. Association of interleukin-10 −1082 A/G (rs1800896) polymorphism with susceptibility to gastric cancer: meta-analysis of 6,101 cases and 8,557 controls. Arq Gastroenterol 2018; 55(1): 33–40. <https://doi.org/10.1590/s0004-2803.201800000-18>
8. Wang X, Yang F, Xu G, Zhong S. The roles of IL-6, IL-8 and IL-10 gene polymorphisms in gastric cancer: A meta-analysis. Cytokine 2018; 111: 230–6. <https://doi.org/10.1016/j.cyto.2018.08.024>
9. Hu JJ, Wang ZT, Zhong J. Lack of association between the interleukin 6 gene −174G&gt;C polymorphism and colorectal cancer: evidence from a meta-analysis. Genet Mol Res 2013; 12(3): 2205–14. <https://doi.org/10.4238/2013.July.8.2>
10. Ma H, Sun G, Wang W, Zhou Y, Liu D, Tong Y, et al. Association Between Interleukin-6 −572 C>G and −174 G>C Polymorphisms and Hypertension: A Meta-analysis of Case-control Studies. Medicine (Baltimore) 2016; 95(2): e2416. <https://doi.org/10.1097/MD.0000000000002416> <PubMed>
11. Hefler LA, Grimm C, Lantzsch T, et al. Interleukin-1 and Interleukin- 6 Gene Polymorphisms and the Risk of Breast Cancer in Caucasian Women. Clin Cancer Res 2005; 11(16): 5718–21. <https://doi.org/10.1158/1078-0432.CCR-05-0001>
12. Landi S, Moreno V, Gioia-Patricola L, et al. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res 2003; 63(13): 3560–6.
13. Theodoropoulos G, Papaconstantinou I, Felekouras E, et al. Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol 2006; 12(31): 5037–43. <https://doi.org/10.3748/wjg.v12.i31.5037> <PubMed>
14. Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N. Inflammation- Related Gene Polymorphisms and Colorectal Adenoma. Cancer Epidemiol Biomarkers Prev 2006; 15(6): 1126–31. <https://doi.org/10.1158/1055-9965.EPI-06-0042>
15. Gaustadnes M, Ørntoft TF, Jensen JL, Torring N. Validation of the use of DNA pools and primer extension in association studies of sporadic colorectal cancer for selection of candidate SNPs. Hum Mutat 2006; 27(2): 187–94. <https://doi.org/10.1002/humu.20248>
16. Slattery ML, Wolff RK, Herrick JS, Caan BJ, Potter JD. IL6 genotypes and colon and rectal cancer. Cancer Causes Control 2007; 18(10): 1095–105. <https://doi.org/10.1007/s10552-007-9049-x> <PubMed>
17. Vogel U, Christensen J, Dybdahl M, et al. Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutat Res 2007; 624(1–2): 88–100. <https://doi.org/10.1016/j.mrfmmm.2007.04.006>
18. Wilkening S, Tavelin B, Canzian F, et al. Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis 2008; 29(6): 1202–6. <https://doi.org/10.1093/carcin/bgn101>
19. Küry S, Buecher B, Robiou-du-Pont S, et al. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. BMC Cancer 2008; 8(1): 326. <https://doi.org/10.1186/1471-2407-8-326> <PubMed>
20. Slattery ML, Wolff RK, Curtin K, et al. Colon tumor mutations and epigenetic changes associated with genetic polymorphism: Insight into disease pathways. Mutat Res Mol Mech Mutagen 2009; 660(1–2): 12–21. <https://doi.org/10.1016/j.mrfmmm.2008.10.001> <PubMed>
21. Tsilidis KK, Helzlsouer KJ, Smith MW, et al. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control 2009; 20(9): 1739–51. <https://doi.org/10.1007/s10552-009-9427-7> <PubMed>
22. Vasku JA, Vasku A, Goldbergova M, Vasku V. Heterozygote AG variant of −596 A/G IL-6 gene polymorphism is a marker for cutaneous T-cell lymphoma (CTCL). Clin Immunol 2004; 113(3): 256–60. <https://doi.org/10.1016/j.clim.2004.08.010>
23. Ognjanovic S, Yamamoto J, Saltzman B, et al. Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population. Cancer Causes Control 2010; 21(7): 1131–8. <https://doi.org/10.1007/s10552-010-9540-7>
24. Čačev T, Jokić M, Lončar B, Križanac Š, Kapitanović S. Interleukin-6-174 G/C Polymorphism is Not Associated with IL-6 Expression and Susceptibility to Sporadic Colon Cancer. DNA Cell Biol 2010; 29(4): 177–82. <https://doi.org/10.1089/dna.2009.0950>
25. Abulí A, Fernández-Rozadilla C, Alonso-Espinaco V, et al. Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins. BMC Cancer 2011; 11(1): 339. <https://doi.org/10.1186/1471-2407-11-339> <PubMed>
26. Basavaraju U, Shebl FM, Palmer AJ, et al. Cytokine gene polymorphisms, cytokine levels and the risk of colorectal neoplasia in a screened population of Northeast Scotland. Eur J Cancer Prev 2015; 24(4): 296–304. <https://doi.org/10.1097/CEJ.0000000000000087> <PubMed>
27. Banday MZ, Balkhi HM, Sameer AS, Chowdri NA, Haq E. Strong association of interleukin-6 −174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study. Tumour Biol 2017; 39(3): 1010428317695940. <https://doi.org/10.1177/1010428317695940>
28. El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124(5): 1193–201. <https://doi.org/10.1016/S0016-5085(03)00157-4>
29. Hwang I-R, Hsu P-I, Peterson LE, et al. Interleukin-6 genetic polymorphisms are not related to Helicobacter pylori-associated gastroduodenal diseases. Helicobacter 2003; 8(2): 142–8. <https://doi.org/10.1046/j.1523-5378.2003.00135.x>
30. Kamangar F, Abnet CC, Hutchinson AA, et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 2006; 17(1): 117–25. <https://doi.org/10.1007/s10552-005-0439-7>
31. Xing P, Xiao D, Zeng Q, Gao W. Relationship between cytokine gene polymorphisms on development and clinical characteristics of gastric adenocarcinoma. Chinese J Gen Surg 2006; 15: 659–63.
32. Deans C, Rose-Zerilli M, Wigmore S, et al. Host Cytokine Genotype is Related to Adverse Prognosis and Systemic Inflammation in Gastro- Oesophageal Cancer. Ann Surg Oncol 2007; 14(2): 329–39. <https://doi.org/10.1245/s10434-006-9122-9>
33. Gatti LL, Burbano RR, Zambaldi-Tunes M, et al. Interleukin-6 polymorphisms, Helicobacter pylori infection in adult Brazilian patients with chronic gastritis and gastric adenocarcinoma. Arch Med Res 2007; 38(5): 551–5. <https://doi.org/10.1016/j.arcmed.2006.12.011>
34. Crusius JBA, Canzian F, Capella G, et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPICEURGAST). Ann Oncol 2008; 19(11): 1894–902. <https://doi.org/10.1093/annonc/mdn400>
35. Zhao Y, Xiao Y, Gao F. Relativity Research on the association between the interleukin-6 gene polymorphisms and risk of gastric cancer in Wuwei Area of Gansu province. Clin J Med 2010; 38(1): 25–7.
36. Pohjanen V-M, Koivurova O-P, Mäkinen JM, et al. Interleukin 6 gene polymorphism −174 is associated with the diffuse type gastric carcinoma. Genes, Chromosom Cancer 2013; 52(10): 976–82. <https://doi.org/10.1002/gcc.22093>
37. Cao C. Multivariate analysis of the correlation between IL-6 174G/C gene polymorphism and gastric cancer. Mod Prev Med 2014; 41(20): 3756–8.
38. Sampaio AM, Balseiro SC, Silva MR, et al. Association Between IL-4 and IL-6 Expression Variants and Gastric Cancer Among Portuguese Population. GE Port J Gastroenterol 2015; 22(4): 143–52. <https://doi.org/10.1016/j.jpge.2015.04.001> <PubMed>
39. Attar M, Mansoori M, Shahbazi M. Interleukin-6 Genetic Variation and Susceptibility to Gastric Cancer in an Iranian Population. Asian Pac J Cancer Prev 2017; 18(11): 3025–9.
40. Wang S, Zhang W. Genetic variants in IL-6/JAK/STAT3 pathway and the risk of CRC. Tumor Biol 2016; 37(5): 6561–9. <https://doi.org/10.1007/s13277-015-4529-1>
41. Liu Y, Xu Y, Wang Y, Yao Y, Yang J. Associations between interleukin gene polymorphisms and the risk of gastric cancer: A meta-analysis. Clin Exp Pharmacol Physiol 2018; 45(12): 1236–44. <https://doi.org/10.1111/1440-1681.13021>
42. Zare M, Jafari-Nedooshan J, Jafari M, et al. Relevance of hMLH1 −93G&gt;A, 655A&gt;G and 1151T&gt;A polymorphisms with colorectal cancer susceptibility: a meta-analysis based on 38 case-control studies. Rev Assoc Med Bras 2018; 64(10): 942–51. <https://doi.org/10.1590/1806-9282.64.10.942>
43. Moghimi M, Kargar S, Jafari MA, et al. Angiotensin Converting Enzyme Insertion/Deletion Polymorphism is Associated with Breast Cancer Risk: A Meta-Analysis. Asian Pacific J Cancer Prev 2018; 19(11): 3225–31. <https://doi.org/10.31557/APJCP.2018.19.11.3225> <PubMed>
44. Abedinzadeh M, Zare-Shehneh M, Neamatzadeh H, Abedinzadeh M, Karami H. Association between MTHFR C677T polymorphism and risk of prostate cancer: Evidence from 22 studies with 10,832 cases and 11,993 controls. Asian Pacific J Cancer Prev 2015; 16(11): 4525–30. <https://doi.org/10.7314/APJCP.2015.16.11.4525>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive